143 related articles for article (PubMed ID: 36135777)
1. Factors associated with cytomegalovirus infection in antineutrophil cytoplasmic antibody-associated vasculitis: A narrative review.
Leong A; Fong W
Int J Rheum Dis; 2022 Dec; 25(12):1357-1367. PubMed ID: 36135777
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Morishita M; Sada KE; Matsumoto Y; Hayashi K; Asano Y; Hiramatsu Asano S; Ohashi K; Miyawaki Y; Katsuyama E; Watanabe H; Kawabata T; Wada J
PLoS One; 2019; 14(7):e0218705. PubMed ID: 31291263
[TBL] [Abstract][Full Text] [Related]
3. Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.
Chanouzas D; Dyall L; Nightingale P; Ferro C; Moss P; Morgan MD; Harper L
Trials; 2016 Jul; 17(1):338. PubMed ID: 27450392
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Clinical Features and Association between Vascular Endothelial Injury Markers and Cytomegalovirus Infection Associated with Thrombotic Microangiopathy in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Case-Based Research.
Nimura T; Aomura D; Harada M; Yamaguchi A; Yamaka K; Nakajima T; Tanaka N; Ehara T; Hashimoto K; Kamijo Y
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255886
[TBL] [Abstract][Full Text] [Related]
5. Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis, using a Japanese health insurance database.
Sakai R; Tanaka E; Nishina H; Suzuki M; Yamanaka H; Harigai M
Int J Rheum Dis; 2019 Nov; 22(11):1978-1984. PubMed ID: 31338986
[TBL] [Abstract][Full Text] [Related]
6. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
Erden A; Bolek EC; Yardimci KG; Kilic L; Bilgen SA; Karadag O
Int J Rheum Dis; 2019 Oct; 22(10):1926-1932. PubMed ID: 31571413
[TBL] [Abstract][Full Text] [Related]
7. CD4
Slot MC; Kroon AA; Damoiseaux JGMC; Theunissen R; Houben AJHM; de Leeuw PW; Tervaert JWC
Rheumatol Int; 2017 May; 37(5):791-798. PubMed ID: 28084533
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection?
Meyer MF; Hellmich B; Kotterba S; Schatz H
Rheumatol Int; 2000 Dec; 20(1):35-8. PubMed ID: 11149660
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
[TBL] [Abstract][Full Text] [Related]
10. Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis.
Yoo J; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2018 Aug; 37(8):2133-2141. PubMed ID: 29557539
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
13. Predictive Factors of Cytomegalovirus Viremia during the Clinical Course of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Single Center Observational Study.
Harada M; Iwabuchi R; Yamaguchi A; Aomura D; Yamada Y; Sonoda K; Kamimura Y; Hashimoto K; Kamijo Y
J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615150
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation.
Gibson LE
Int J Dermatol; 2022 Dec; 61(12):1442-1451. PubMed ID: 35599359
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis.
King C; Patel R; Mendoza C; Walker JK; Wu EY; Moss P; Morgan MD; O'Dell Bunch D; Harper L; Chanouzas D
Arthritis Res Ther; 2022 Aug; 24(1):192. PubMed ID: 35948984
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Influence on the Disease Outcome.
Garcia-Vives E; Segarra-Medrano A; Martinez-Valle F; Agraz I; Solans-Laque R
J Rheumatol; 2020 Mar; 47(3):407-414. PubMed ID: 31203229
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Beketova TV
Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
[TBL] [Abstract][Full Text] [Related]
18. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
19. Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.
McAdoo SP; Hall A; Levy J; Salama AD; Pusey CD
J Clin Rheumatol; 2012 Oct; 18(7):336-40. PubMed ID: 23047533
[TBL] [Abstract][Full Text] [Related]
20. The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis.
Chanouzas D; Sagmeister M; Dyall L; Sharp P; Powley L; Johal S; Bowen J; Nightingale P; Ferro CJ; Morgan MD; Moss P; Harper L
Arthritis Res Ther; 2018 Aug; 20(1):194. PubMed ID: 30157919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
